Cara Therapeutics Inc. (NASDAQ: CARA) Stock Information | RedChip

Cara Therapeutics Inc. (NASDAQ: CARA) Listen to this Section


$0.33
N/A ( 0% ) 73.8K

Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.

Market Data


Open


$0.33

Previous close


$0.33

Volume


73.8K

Market cap


$18.10M

Day range


$0.33 - $0.34

52 week range


$0.24 - $3.06

Insider Ownership Transactions

Total Amount Purchased: -166,189.00 | $ -54,011.43

Date Type Amount Purchased Purchaser
2024-03-04 Sale -3293.00 Terrillion Scott
2024-03-04 Sale -3293.00 Goncalves Joana
2024-02-12 Sale -5488.00 Maynard Ryan D
2024-02-12 Sale -7770.00 Terrillion Scott
2024-02-12 Sale -7770.00 Goncalves Joana
2024-02-12 Sale -35575.00 Posner Christopher
2024-02-05 Sale -13500.00 Menzaghi Frederique Ph.D.
2024-02-05 Sale -13500.00 Terrillion Scott
2024-02-05 Sale -62500.00 Posner Christopher
2024-02-05 Sale -13500.00 Maynard Ryan D

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 06, 2024
10-q Quarterly Reports 91 May 13, 2024
8-k 8K-related 15 May 13, 2024
4 Insider transactions 1 May 06, 2024
ars Annual reports 1 Apr 22, 2024
def Proxies and info statements 6 Apr 22, 2024
pre Proxies and info statements 6 Apr 12, 2024
4 Insider transactions 1 Apr 09, 2024
4 Insider transactions 1 Apr 09, 2024
8-k 8K-related 13 Mar 22, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.